Immune checkpoint receptors such as programmed cell death protein 1 (PD1) inhibit the activities of effector T cells and tumor cells by expressing these molecules can impede anti-tumor responses of the immune system [5]. This evidence concerns the gene PDCD1 and neoplasm.